WithdrawnNot Applicable

Evaluation of Safety and Performance of the Orbix Breast Lift System

Stopped: No EC approval obtained

Netherlands0

Plain-language summary

The study is using a new breast lift system to complement a breast-lift operation. In general there will be recurrence of breast-ptosis after a correcting operation. With this device we want to minimize this recurrence and provide an "internal bra".

Who can participate

Age range30 Years – 50 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓.Female subject between 30-50 years of age 2. Subject is referred for mastopexy(breast lifting)due to one of the following reasons:

Exclusion criteria

✕. Pregnant or lactating women
✕. history of surgical procedures involving the ribs and rib cage
✕. Osteoporosis
✕. breast implants
✕. breast carcinoma
✕. auto-immune disease -

What they're measuring

Result after using the breast lift system,recurrence of ptosis.

Timeframe: one year

Trial details

NCT IDNCT00774059

SponsorMaastricht University Medical Center

Sponsor typeOTHER

Study typeINTERVENTIONAL

View on ClinicalTrials.gov More Breast Ptosis trials